Sotiris Lakis

Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer

Kristen S. Purrington, Susan Slager, Diana Eccles et al. · Carcinogenesis · 2013 · 160 citations · Full text

Life Sciences, Genetics, Oncology +17

Tumors with high-density tumor infiltrating lymphocytes constitute a favorable entity in breast cancer: a pooled analysis of four prospective adjuvant trials

Vassiliki Kotoula, Kyriakos Chatzopoulos, Sotiris Lakis et al. · Oncotarget · 2015 · 66 citations · Full text

Medicine, Oncology, Pathology +16

Technical validation of an RT-qPCR in vitro diagnostic test system for the determination of breast cancer molecular subtypes by quantification of ERBB2, ESR1, PGR and MKI67 mRNA levels from formalin-fixed paraffin-embedded breast tumor specimens

Mark Laible, Kornelia Schlombs, Katharina Kaiser et al. · BMC Cancer · 2016 · 55 citations · Full text

Medicine, Oncology, Pathology +17

Prognostic Evaluation of Epidermal Growth Factor Receptor (EGFR) Genotype and Phenotype Parameters in Triple-negative Breast Cancers

Sofia Levva, Vassiliki Kotoula, Ioannis Kostopoulos et al. · Cancer Genomics & Proteomics · 2017 · 47 citations · Full text

Medicine, Molecular Medicine, Oncology +17

TP53 mutations and protein immunopositivity may predict for poor outcome but also for trastuzumab benefit in patients with early breast cancer treated in the adjuvant setting

George Fountzilas, Eleni Giannoulatou, Zoi Alexopoulou et al. · Oncotarget · 2016 · 37 citations · Full text

Medicine, Molecular Medicine, Oncology +16